Amgen wins appeal in US patent case over generic psoriasis drugs
By Blake Brittain (Reuters) – Amgen Inc convinced a U.S. appeals court on Wednesday to uphold patents that barred generic versions of its blockbuster psoriasis drug Otezla proposed by Zydus…